Log in


Complementary Medicines Australia supports appropriate government regulation for complementary healthcare products that recognises the low risk nature of the products whilst upholding safety, quality and efficacy standards necessary to ensure consumer confidence.

Submissions to the Therapeutic Goods Administration

The following submissions are in response to the following TGA consultation documents:


CMA Submission and Position Statement to Sports Supplements Consultation

CMA Submission Caffeine Proposal - P1054 Pure and highly concentrated caffeine products

CMA Submission - EU Guidelines proposal to adopt ICH-Q3D for all listed medicines including herbal medicines.

CMA Submission - (New TGO 101 - Standard for Tablets, Capsules & Pills) - Remaking Therapeutic Goods Order No. 78

CMA Submission - TGA Fees and Charges 2019-2020

2019 Other Submissions

30 October 2019  Consultation Regulation Impact Statement for the Legislative & Governance Forum on Consumer Affairs - Clarifying eligibility for origin claims in the Complementary Medicines Sector

January 2019 CMA Submission - Complementary Healthcare Sector Country of Origin Labelling Government Taskforce


CMA Submission - Complaints handling - Advertising of therapeutic goods to the public (June 2018)
CMA Submission -  Adoption of the European Union Guidelines – Ethanol & Boron (May 2018)

CMA Submission - The 2018 Therapeutic Goods Advertising Code & associated guidance (April 2018)
CMA Member Only Version - The 2018 Therapeutic Goods Advertising Code & associated guidance (April 2018)

CMA Submission- Proposal to change the current good manufacturing practice (GMP) fees and charges ( March 2018)

CMA Submission - Discontinuing pre-market evaluation of Herbal Component Names (12 January 2018)


CMA Submission - Business process improvements supporting complementary medicines assessments pathways (7 November 2017)

CMA Submission - Permitted Indications (1) - Health maintenance biomarker claims (October 2017)

CMA Submission - Permitted Indications (2) - Mild and Medically Diagnosed Conditions (October 2017)

CMA Submission - Permitted Indications (3) - Maternal Health & Infancy (October 2017)

CMA Submission - Permitted Indications (4) - Tradition of Use Evidence Qualifiers (October 2017)

CMA Submission - Therapeutic Goods Advertising Code Proposed improvements (13 October 2017)

CMA Submission - Exposure Draft of the Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017 (5 September 2017)

CMA Submission: Enhancing Sanctions and Penalties in the Therapeutic Goods Act 1989 (31 May 2017)

CMA submission to the consultation - Options for the future regulation of 'low risk' products (12 May 2017)

CMA submission to the consultation - Reforms to the regulatory framework for complementary medicines: Assessment pathways (28 March 2017)

CMA submission to the Therapeutic Goods Amendment (2016 Measures No. 1) Bill 2016 inquiry. - Click here to read the submission (3 March 2017)

Food Standards Australian New Zealand Submissions:

CMA Submission to FSANZ - Proposal P1044 - Plain English Allergen Labelling (PEAL) (May 2018)

Click Here for older submissions


CMA's goal is to achieve a sustainable vibrant, compliant industry that holds its place in consumer health. We support the ethical and responsible promotion of complementary healthcare products and their value to the health of our community.

Call us on 02 6260 4022 or fax 02 6260 4122

Address: PO Box 450 Mawson, ACT 2607 Australia

Powered by Wild Apricot Membership Software